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Effects of Phacoemulsification and
Intraocular Lens Implantation on the
Corneal Endothelium in Primary
Angle-closure Glaucoma
Yu-Chieh Ko, Catherine Jui-Ling Liu, Joe C. Chou and Wen-Ming Hsu
Background: Phacoemulsification and intraocular lens implantation (P-IOL) is
an option for intraocular pressure (IOP) control for primary angle-closure glaucoma
(PACG). This study examined the effects of P-IOL on the corneal endothelium in
eyes with PACG.
Patients and Methods: Ultrasound biometry and pachymetry, as well as specular
microscopy, were performed preoperatively and 3 months after surgery in 24 eyes
with PACG that underwent P-IOL. The postoperative changes in central corneal
endothelial density and central corneal thickness (CCT) were evaluated. The correlations
between postoperative endothelial changes and both preoperative IOP control and
biometric features were analyzed.
Results: After surgery, corneal endothelial cell density decreased significantly
(p < 0.001), with a mean cell loss of 15.7%, and mean CCT increased by 7 +m
(p = 0.034). A greater postoperative corneal endothelial loss was correlated with
a higher preoperative mean IOP and more glaucoma medications (correlation
coefficients = 0.487 and 0.427, p = 0.016 and 0.038, respectively). The corneal
endothelial changes did not correlate with preoperative biometric features including
anterior chamber depth, lens thickness, and axial length.
Conclusion: Significant corneal endothelial cell loss after P-IOL in PACG patients
suggests that corneal endothelium status should be carefully evaluated before
performing this surgery in these patients, especially those with poor preoperative
IOP control.
(J Med Ultrasound 2004;12:33–7)
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INTRODUCTION
Predisposing factors for primary angle-closure
glaucoma (PACG) relate primarily to a small,
crowded anterior segment, including a shallow
anterior chamber and a thick, anteriorly positioned
lens [1]. Peripheral iridotomy (PI) is the intial surgical
treatment of choice for PACG [2]. It relieves the
pupillary block mechanism that is responsible for
most cases of PACG and precipitates the cascade
of anatomic angle closure. However, accumulating
evidence indicates that many PACG eyes require
further treatment to control intraocular pressure (IOP),
even with patent PI [3,4]. Traditionally, the elevated
IOP in iridotomized eyes is treated in stages: medical
therapy first, followed by glaucoma filtering surgery
if the IOP remains uncontrolled. Unlike glaucoma
filtering surgery, the purpose of lens extraction with
intraocular lens (IOL) implantation in PACG is to
restore a normal iridocorneal anatomic relationship.
Several studies have shown that cataract surgery
with posterior chamber IOL implantation in PACG
eyes may result in lower mean IOP with the need
for fewer glaucoma medications [5–7]. Compared
with extracapsular cataract extraction (ECCE),
phacoemulsification has the advantages of a smaller
incision, less iris manipulation, better intraoperative
maintenance of the anterior chamber, less risk of iris
prolapse, and better preservation of the chamber
angle. However, the ocular characteristics of PACG,
such as a shallow anterior chamber, which makes
the corneal endothelium more vulnerable to ultra-
sound or turbulent flow damage, and fewer corneal
endothelial cells, on which surgical trauma may lead
to postoperative corneal decompensation, make
phacoemulsification and IOL implantation (P-IOL)
more challenging [8,9]. In addition, pupillary miosis
with posterior synechia in eyes treated with
pilocarpine over long periods will complicate the
situation even further by obscuring part of the surgical
field.
In this study, we investigated the effects of P-
IOL on corneal endothelial cell density and central
corneal thickness (CCT), as CCT may reflect the
function of the endothelium, in eyes with primary
angle closure.
PATIENTS AND METHODS
Patients with primary angle closure undergoing P-
IOL between July 2003 and February 2004 were
enrolled and followed prospectively for at least 3
months. All patients had a normal cornea on
biomicroscopy and had previously undergone a
PI. Eyes with occludable angles secondary to
inflammation, trauma, tumor, neovascularization,
iridocorneal endothelial syndrome, or aqueous
misdirection were not included. Eyes with a history
of incision ocular surgery, total peripheral anterior
synechia extending up to Schwalbe’s line, advanced
glaucomatous visual field defects threatening central
vision, or retinal vascular disorders were also
excluded.
All patients underwent examination preoperatively
and 3 months after surgery in both eyes. Ultrasound
biometry was performed using the TOMEY Bio and
Pachy Meter (AL-1000, Tomey Corp, Nagayo, Aichi,
Japan) to measure the anterior chamber depth (ACD),
lens thickness (LT), and axial length (AL). Central
corneal endothelial cell density was measured using
a non-contact specular microscope (SD-9000, Konan
Inc, Nishinomiya, Hyogo, Japan). An ultrasound
pachymeter (DGH-550, DGH Technology Inc, Frazer,
PA, USA) was used to measure CCT. Each biometric
measurement was repeated three times for each eye
and the mean of the three readings was used for
analysis.
Except for replacing prostaglandin analogue with
oral acetazolamide, 125 mg every 6 hours for 3
weeks starting from the day of surgery, preoperative
glaucoma medications were maintained during the
perioperative period. Postoperative glaucoma med-
ications were adjusted according to changes in IOP.
Clear cornea phacoemulsification was performed by
one surgeon (C. Liu) using a 3.2-mm incision, manual
continuous curvilinear capsulorhexis, and a divide-
and-conquer or stop-and-chop technique in the cap-
sular bag using the Storz Protégé phacoemulsi-
fier (DPX100, Storz Instrument Co, St. Louis, MO,
USA) with an adjustable ultrasound power kept
below 45%. After the nucleus and cortex had been
removed, the incision was enlarged appropriately to
accommodate a one-piece PMMA IOL (MZ30BD,
Alcon Laboratories Inc, Houston, TX, USA) or a
foldable acrylic IOL (MA60BM, Acrysoft, Alcon
Laboratories Inc). In cases with a small synechic
pupil, the pupil was enlarged by dissecting the
posterior synechia using sodium chondroitin-sodium
hyaluronate (Viscoat®). The number of glaucoma
medications needed to maintain acceptable IOP
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control preoperatively and 3 months after surgery
was recorded.
Data were analyzed with SPSS version 10.0 (SPSS
Inc, Chicago, IL, USA) for Windows. Corneal
condition before and after phacoemulsification was
compared using the Wilcoxon signed rank test. The
correlations between the patients’ preoperative
characteristics and both postoperative endothelial
cell loss and changes in CCT were analyzed using
the Spearman correlation coefficient. The level of
significance was set at p less than 0.05.
RESULTS
Twenty-four patients were included in the study and
clinical data are listed in Table 1. The preoperative
means ( standard deviations for ACD, LT, and AL
were 2.27 ( 0.26 mm, 5.03 ( 0.41 mm, and 22.52 (
1.12 mm, respectively, in the operated eyes.
Surgery was uneventful and the IOL was
positioned in the bag in each eye. Vision improved
significantly after surgery (p < 0.001). The IOP was
better controlled with fewer medications post-
operatively and the vertical cup-to-disc ratio remained
unchanged (Table 1).
The cornea was clear on biomicroscopy 3 months
after surgery in each operated eye. However, corneal
endothelial density decreased significantly post-
operatively (p < 0.001), with a mean cell loss of
15.7%. In addition, the mean postoperative CCT
increased by 7 +m (p = 0.034) (Table 2). No
significant postoperative changes were observed in
central corneal endothelial density or CCT in
unoperated fellow eyes.
The percentage endothelial cell loss was correlated
with preoperative IOP (correlation coefficient,
r, = 0.487; p = 0.016) and the number of glaucoma
medications used (r = 0.427; p = 0.038), but not
with the type of IOL inserted or the biometric features
ACD, LT, and AL. Furthermore, the preoperative
endothelial cell count did not predict postoperative
cell loss.
DISCUSSION
Predisposing factors for PACG include a shallow
anterior chamber, a small corneal diameter and radius
of curvature, a thick lens with steep anterior surface
curvature, an anterior lens position, and a short axial
length of the globe [1,10]. These anatomic factors
influence the anterior chamber configuration and
suggest the contribution of a lens component in the
disease process of PACG. Several studies have shown
that cataract, even clear lens, extraction is effective
in treating PACG patients whose disease cannot be
controlled medically after PI [5–7]. Furthermore, in
cases of acute PACG, primary phacoemulsification
is safe and even more effective in reducing IOP than
surgical PI [4,11]. However, the effects of phaco-
emulsification on the already-compromised corneal
endothelium in patients with PACG have not been
thoroughly evaluated. Compared to age-matched
controls, the corneal endothelial count is significantly
lower in PACG patients [8,9]. The mean endothelial
cell loss can be as high as 35% after an acute glau-
coma attack [8]. Although it is not known whether
the residual endothelium is at risk for further damage,
procedures potentially hazardous to the endothelium
should be handled with great care in these patients.
In this study, P-IOL in PACG eyes resulted in
a mean endothelial cell loss of 15.7%. This figure
is higher than the average 10% reduction in endo-
thelial cell density after phacoemulsification in non-
glaucomatous eyes [12,13], but lower than the
18.3% decrease in 18 PACG eyes that underwent
P-IOL reported by Kubota et al [6]. In addition,
Table 1. Pre- and postoperative clinical data
Preoperative Postoperative p
Vision (ETDRS chart) 52.65 ( 11.40 69.00 ( 6.47 < 0.001
Intraocular pressure (mmHg) 14.75 ( 4.87 11.83 ( 3.57 0.002
Vertical cup-to-disc ratio 0.62 ( 0.19 0.59 ( 0.22 0.222
No. of glaucoma medications 1.17 ( 1.2 0.375 ( 0.77 0.002
ETDRS = early treatment of diabetic retinopathy study.
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some studies have reported transient corneal de-
compensation after uneventful cataract surgery in
eyes with PACG [5,14].
In a prospective study of 859 eyes, Hayashi et
al identified the firmness of the nucleus as the most
significant risk factor for endothelial cell loss and
suggested that mechanical contact with nuclear
fragments is the principal cause of endothelial injury
[15]. Additionally, they reported that a small pupil
diameter was also associated with endothelial cell
loss. In PACG eyes, the shallow ACD and small
anterior chamber volume may increase the chance
of contact between lens fragments and the corneal
endothelium. The ACDs in our subjects were shal-
lower than that in the general population, between
1.92 and 2.58 mm, which is comparable to the
results of previous studies of PACG [16,17]. How-
ever, no significant correlation between percentage
endothelial cell loss and ACD was identified in our
study, which may have been influenced by the nar-
row range of ACD distribution. To verify a possible
relationship between ACD and corneal endothelial
cell loss after P-IOL, we would need to recruit more
PACG eyes or compare cell loss between primary
open angle glaucoma and PACG eyes, controlling
for factors that may influence the corneal endothelium
other than ACD.
 We found a positive correlation between per-
cent postoperative endothelial cell loss and both
preoperative IOP and the number of preoperative
glaucoma medications. It is probable that the
endothelial cells in eyes with higher preoperative
IOP are under greater stress than in eyes with lower
IOP, making them more susceptible to surgical in-
jury. Gagnon et al found that corneal endothelial
cell counts in glaucomatous eyes were inversely
proportional to mean IOPs measured during the
previous 24 months [9]. Sihota et al compared corneal
endothelium status among different subtypes of
PACG and found that patients with an acute attack
had the lowest endothelial cell counts and highest
CCTs, especially those with attacks lasting more
than 72 hours [8]. They also reported that patients
with symptomatic chronic PACG had lower
endothelial cell counts than their asymptomatic
counterparts [8].
On the other hand, the disease process of glau-
coma may involve both the corneal endothelium
and endothelial-like trabecular meshwork (TM) cells.
Alvarado et al described lower TM cell counts in
glaucomatous eyes, and a predisposition to TM cell
loss through a pressure-dependent mechanism can-
not be ruled out [18]. Finally, medication toxicity
may result in endothelial cell abnormality and make
cells more vulnerable. In the Gagnon et al study,
patients receiving three or four glaucoma medica-
tions had lower cell counts than those receiving
one or two [9].
Although the corneas of all subjects remained
clear on biomicroscopy, the mean CCT increased by
7 +m postoperatively. Whether the change in CCT
implies a mild dysfunction of the corneal endothelium
or merely reflects a long-term measurement variation
by the equipment requires further research. Studies
by Bourne et al and Liesegang et al have reported
continued endothelial cell loss up to 10 years after
ECCE [19,20].
This was a short-term study and continued follow-
up is needed to more comprehensively evaluate the
impact of P-IOL on the corneal endothelium. In
view of the higher percentage endothelial cell loss
in PACG than non-glaucomatous eyes after P-IOL,
we emphasize the importance of taking great care
to protect the corneal endothelium while performing
surgery in eyes with a shallow anterior chamber,
especially in patients with high IOP or those being
treated with several glaucoma medications.
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